Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new serotonin 5-HT6 receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
Juan A. González‐Vera, Rocío A. Medina, Mar Martín‐Fontecha, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study
Hui-Xian Chong, Najwadi Yusoff, Yan-Yan Hor, et al.
Beneficial Microbes (2019) Vol. 10, Iss. 4, pp. 355-374
Closed Access | Times Cited: 159
G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
Shofiul Azam, Md. Ezazul Haque, Md. Jakaria, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 506-506
Open Access | Times Cited: 101
Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands
Laura Blaikie, Graeme Kay, Paul Kong Thoo Lin
MedChemComm (2019) Vol. 10, Iss. 12, pp. 2052-2072
Open Access | Times Cited: 85
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases
David Vanda, Paweł Zajdel, Miroslav Soural
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111569-111569
Closed Access | Times Cited: 75
Antagonism of the 5-HT 6 receptor – Preclinical rationale for the treatment of Alzheimer's disease
Inge E.M. de Jong, Arne Mørk
Neuropharmacology (2017) Vol. 125, pp. 50-63
Closed Access | Times Cited: 70
Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation
Zhaohui Yao, Xiaoli Yao, Yong Zhang, et al.
Neurochemical Research (2018) Vol. 43, Iss. 4, pp. 806-820
Closed Access | Times Cited: 69
Halogen bonding in halocarbon-protein complexes and computational tools for rational drug design
Paulo J. Costa, Rafael Nunes, Diogo Vila‐Viçosa
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 8, pp. 805-820
Closed Access | Times Cited: 57
Halogen Bonding: An Underestimated Player in Membrane–Ligand Interactions
Rafael Nunes, Diogo Vila‐Viçosa, Paulo J. Costa
Journal of the American Chemical Society (2021) Vol. 143, Iss. 11, pp. 4253-4267
Open Access | Times Cited: 53
Benzimidazole and Benzoxazole Derivatives Against Alzheimer's Disease
Nagihan Faydalı, Özlem Temiz‐Arpacı
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 8
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
Anna Więckowska, Tomasz Wichur, Justyna Godyń, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 5, pp. 1195-1214
Closed Access | Times Cited: 52
Manganese Catalyzed Direct Amidation of Esters with Amines
Zhengqiang Fu, Xinghua Wang, Tao Sheng, et al.
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 3, pp. 2339-2358
Closed Access | Times Cited: 41
Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease
Katarzyna Kucwaj‐Brysz, Hanna Baltrukevich, Kinga Czarnota, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128275-128275
Open Access | Times Cited: 35
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
Jakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111857-111857
Open Access | Times Cited: 36
Biomolecular Simulations of Halogen Bonds with a GROMOS Force Field
Rafael Nunes, Diogo Vila‐Viçosa, Miguel Machuqueiro, et al.
Journal of Chemical Theory and Computation (2018) Vol. 14, Iss. 10, pp. 5383-5392
Closed Access | Times Cited: 35
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity
Katarzyna Grychowska, Séverine Chaumont‐Dubel, Rafał Kurczab, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3183-3196
Open Access | Times Cited: 30
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117995-117995
Closed Access
Design and development of stapled transmembrane peptides that disrupt the activity of G-protein–coupled receptor oligomers
Joaquín Botta, Lučka Bibič, Patrick M. Killoran, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 45, pp. 16587-16603
Open Access | Times Cited: 28
Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States
David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 2, pp. 1180-1196
Closed Access | Times Cited: 20
Computer-Aided Studies for Novel Arylhydantoin 1,3,5-Triazine Derivatives as 5-HT6 Serotonin Receptor Ligands with Antidepressive-Like, Anxiolytic and Antiobesity Action In Vivo
Rafał Kurczab, Wesam Ali, Dorota Łażewska, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2529-2529
Open Access | Times Cited: 23
Tripchlorolide May Improve Spatial Cognition Dysfunction and Synaptic Plasticity after Chronic Cerebral Hypoperfusion
Zhaohui Yao, Xiaoli Yao, Shaofeng Zhang, et al.
Neural Plasticity (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 22
2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
Adam S. Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2019) Vol. 179, pp. 1-15
Closed Access | Times Cited: 21
Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo
Sylwia Sudoł, Katarzyna Kucwaj‐Brysz, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112529-112529
Open Access | Times Cited: 19
Tackling Halogenated Species with PBSA: Effect of Emulating the σ-Hole
Rafael Nunes, Diogo Vila‐Viçosa, Paulo J. Costa
Journal of Chemical Theory and Computation (2019) Vol. 15, Iss. 7, pp. 4241-4251
Open Access | Times Cited: 18
Exploring Halogen Bonds in 5-Hydroxytryptamine 2B Receptor–Ligand Interactions
Yu Zhou, Yuanxun Wang, Pengfei Li, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 9, Iss. 10, pp. 1019-1024
Open Access | Times Cited: 17
Existence of untypical halogen-involving interactions in crystal packings: a statistical and first-principles study
Yaser Balmohammadi, Hamid Reza Khavasi, S. Shahab Naghavi
CrystEngComm (2020) Vol. 22, Iss. 16, pp. 2756-2765
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top